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Abstract
Background: Advances in treatment mean that most children diagnosed with cancer 
during childhood survive. Therefore, it is increasingly important to examine the 
long‐term consequences of childhood cancer, including educational attainment. This 
systematic review investigated whether the educational attainment of childhood can-
cer survivors differ from the cancer‐free population.
Design/methods: We searched seven databases for articles published from January 
2005 to August 2018. We identified full papers in English, reporting primary data on 
academic attainment of adult survivors of childhood cancer, compared to a control 
group. Quality appraisal was conducted using the Newcastle‐Ottawa Scale.
Results: Fourteen studies met the inclusion criteria. Nine papers included patients 
with various types of cancers, four focused on a single type of cancer, and one on 
patients who underwent stem cell transplantation.
Of the 14 papers, 2 studies were considered good quality, 10 were considered adequate 
quality, and 2 were considered poor quality. Four studies reported more favorable edu-
cational attainment among survivors while six did not report significant differences. 
Less favorable attainment was consistently reported for CNS survivors in four studies.
Conclusion: The literature does not provide a clear pattern of the long‐term consequences 
of childhood cancer on education attainment. While this may suggest that there is no 
consistent difference between the education attainment of cancer survivors and controls, 
it may also be the result of limitations in the existing research. To better assess the educa-
tion attainment of survivors, there is a need for high‐quality studies, with appropriate 
comparators, and standardized measures of education attainment across countries.
K E Y W O R D S
cancer, childhood all, educational attainment, survivorship, systematic review
1 |  INTRODUCTION
Cancer is increasingly recognized as a chronic illness. The 
life trajectory of those diagnosed is no longer one of inexo-
rable decline. Instead, around 66% of all patients and around 
80% of childhood cancers patients now survive 5 years or 
longer.1,2 This means that the population of childhood cancer 
survivors is rising; in the USA, for example, there are almost 
400 000 childhood cancer survivors,3 and around 100 000 in 
Europe.4
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With the rapid improvement in childhood cancer survival 
over the past three decades, increasing attention is being paid 
to the quality of survival. Studies have highlighted a range of 
difficulties experienced by childhood cancers survivors, includ-
ing physical, social, and emotional problems.5,6 It is estimated 
that, due to the toxicity of the available treatments, up to 90% 
of survivors of childhood cancer experience some late effects 
of treatment, and around one‐third have a severe, disabling, or 
life‐threatening chronic conditions.3,8 Survivors have a 6‐11 
times higher risk of death than the general population and, even 
45 years after treatment, the risk is three‐times higher than ex-
pected.9,10 In terms of morbidities, alongside pain, functional 
impairment, and impaired mental health, 35% of survivors have 
neurocognitive dysfunction,3 that can impact the academic 
performance of children with cancer and, potentially, result in 
poorer educational outcomes.
Education is a key predictor of future employment, in-
come, and, in general, integration in society. Thus, educa-
tional attainment may be considered a key measure of the 
quality of long‐term survivorship. As well as the impact 
that treatment may have on cognition,11,12 the education of 
survivors may also be adversely affected by missing time 
in school due to treatment, thus falling behind on school-
work.18 Some studies estimate that 50% of children with 
cancer attend school in the first month after start of treat-
ment. This increases to 70% of children in month 4 after 
start of treatment,19 but absenteeism in children with brain 
tumors is higher than for those with other cancers.20,21 
Irregular school attendance has been reported to last years 
after the end of treatment,21 adding to the educational diffi-
culties experienced by survivors.5,22,23 However, while the 
cognitive effects of treatment have been extensively inves-
tigated,3 and interventions for addressing educational diffi-
culties have been introduced in some settings,24,25 to date, 
a systematic review of the international evidence on educa-
tional outcomes among survivors has not been published. 
This paper reports the results of a systematic review that 
investigated the long‐term effects of cancer on the educa-
tional attainment of childhood cancer survivors compared 
to children without cancer.
2 |  METHODS
2.1 | Search strategy
We adhered to the Preferred Reporting Items for Systematic 
Reviews and Meta‐Analyses guidelines in conducting this 
review and preparing the manuscript.26 We searched seven 
databases (SCOPUS, Web of Science, EBSCO, EMBASE, 
ProQuest, RIAN, and the Applied Social Sciences Index and 
Abstracts), as well as citation lists of eligible papers, to iden-
tify studies reporting educational attainment of childhood 
cancer survivors published during 1 January 2005‐3 August 
2018. The search combined terms (both MeSH headings and 
keywords) for the population of interest and those relating to 
educational attainment, including: childhood cancer, cancer, 
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T A B L E  1  Description of the studies included in the review
 Country Study design1
Sample size Source(s) of data
Cancers included
Outcome assessment
Cases Comparators Cases Comparators Cases Comparator
Boman et al 
(2009)39
Sweden R 531 996 Registry Population survey CNS Survey Survey
Boman et al 
(2010)29
Sweden P; linkage 1457 1 457 805 Registry Population register ALL, Lymphoma, CNS, Brain 
tumor, Other
Education Register Education Register
Dieluweit et al 
(2011)31
Germany R 820 850 Registry Socio Economic Panel  
study (matched)
ALL, Lymphoma, CNS, 
Neuroblastoma, 
Renal tumor, 
Bone tumor, 
Soft tissue tumor. 
GCT, 
Other
Self‐completion questionnaire Face‐to‐face interview
Dumas et al 
(2016)32
France R 2066 Not reported Hospital Household survey ALL, 
Lymphoma, 
Bone or soft tissue sarcoma, 
Nephroblastoma, 
Others
Self‐completion questionnaire Not reported
Gerhardt et al 
(2007)41
USA R 56 60 Hospital Class mates ALL, Lymphoma, Other non‐CNS 
tumor
Face‐to face interviews Face‐to face interviews
Ghaderi et al 
(2015)
Norway P; data linkage 2213 1 212 623 Registry Population register Mixed (not specified) Population register Population register
Jacola et al (2016)40 USA R 691 259 Hospital Siblings ALL Self‐completion questionnaire Self‐completion questionnaire
Jóhannsdóttir et al 
(2010)33
Sweden, 
Denmark, 
Finland, 
Norway, Iceland
R 247 1814 Registry Census study AML, 
Wilms tumor, Astrocytoma
Self‐completion questionnaire Self‐completion questionnaire
Kuehni et al 
(2012)34
Switzerland R 961 5207 Registry Population survey ALL, 
Lymphoma, 
CNS, 
Neuroblastoma, 
Retinoblastoma, 
Renal tumor, 
Hepatic tumor, 
Bone tumors, 
Soft tissue sarcoma, 
GCT, 
Other
Self‐completion questionnaire Face‐to face interview
Löf et al (2011)35 Sweden R 51 2180 Hospital Living Condition Survey Treated with SCT Self‐completion questionnaire Self‐completion questionnaire
Nies et al (2017)36 The Netherlands R 39 Peer: 30; 
Population 
comparison: 
508
Registry Peer controls, Population  
survey
DTC Self‐completion questionnaire Self‐completion questionnaire
Stam et al (2005)42 The Netherlands R 353 508 Hospitals Family doctors ALL, Lymphoma, Solid tumors, 
Brain tumors
Self‐completion questionnaire Self‐completion questionnaire
Yagci‐Kupeli et al 
(2013)38
Turkey R 201 Population 
means
Hospital National statistics office HL, NHL, CNS 
Rhabdomyosarcoma, Wilms 
tumor, Langerhans cell, 
GCT, 
Other
Face‐to‐face interviews Population means
Zynda et al 
(2012)37
Germany R 1476 13 572 Registry National statistics office ALL Self‐completion questionnaire Population means
1 R = retrospective; P = prospective.
   | 3185MOLCHO et aL.
T A B L E  1  Description of the studies included in the review
 Country Study design1
Sample size Source(s) of data
Cancers included
Outcome assessment
Cases Comparators Cases Comparators Cases Comparator
Boman et al 
(2009)39
Sweden R 531 996 Registry Population survey CNS Survey Survey
Boman et al 
(2010)29
Sweden P; linkage 1457 1 457 805 Registry Population register ALL, Lymphoma, CNS, Brain 
tumor, Other
Education Register Education Register
Dieluweit et al 
(2011)31
Germany R 820 850 Registry Socio Economic Panel  
study (matched)
ALL, Lymphoma, CNS, 
Neuroblastoma, 
Renal tumor, 
Bone tumor, 
Soft tissue tumor. 
GCT, 
Other
Self‐completion questionnaire Face‐to‐face interview
Dumas et al 
(2016)32
France R 2066 Not reported Hospital Household survey ALL, 
Lymphoma, 
Bone or soft tissue sarcoma, 
Nephroblastoma, 
Others
Self‐completion questionnaire Not reported
Gerhardt et al 
(2007)41
USA R 56 60 Hospital Class mates ALL, Lymphoma, Other non‐CNS 
tumor
Face‐to face interviews Face‐to face interviews
Ghaderi et al 
(2015)
Norway P; data linkage 2213 1 212 623 Registry Population register Mixed (not specified) Population register Population register
Jacola et al (2016)40 USA R 691 259 Hospital Siblings ALL Self‐completion questionnaire Self‐completion questionnaire
Jóhannsdóttir et al 
(2010)33
Sweden, 
Denmark, 
Finland, 
Norway, Iceland
R 247 1814 Registry Census study AML, 
Wilms tumor, Astrocytoma
Self‐completion questionnaire Self‐completion questionnaire
Kuehni et al 
(2012)34
Switzerland R 961 5207 Registry Population survey ALL, 
Lymphoma, 
CNS, 
Neuroblastoma, 
Retinoblastoma, 
Renal tumor, 
Hepatic tumor, 
Bone tumors, 
Soft tissue sarcoma, 
GCT, 
Other
Self‐completion questionnaire Face‐to face interview
Löf et al (2011)35 Sweden R 51 2180 Hospital Living Condition Survey Treated with SCT Self‐completion questionnaire Self‐completion questionnaire
Nies et al (2017)36 The Netherlands R 39 Peer: 30; 
Population 
comparison: 
508
Registry Peer controls, Population  
survey
DTC Self‐completion questionnaire Self‐completion questionnaire
Stam et al (2005)42 The Netherlands R 353 508 Hospitals Family doctors ALL, Lymphoma, Solid tumors, 
Brain tumors
Self‐completion questionnaire Self‐completion questionnaire
Yagci‐Kupeli et al 
(2013)38
Turkey R 201 Population 
means
Hospital National statistics office HL, NHL, CNS 
Rhabdomyosarcoma, Wilms 
tumor, Langerhans cell, 
GCT, 
Other
Face‐to‐face interviews Population means
Zynda et al 
(2012)37
Germany R 1476 13 572 Registry National statistics office ALL Self‐completion questionnaire Population means
1 R = retrospective; P = prospective.
3186 |   MOLCHO et aL.
childhood, survivor, outcome, psychosocial, edu*, attain*, 
achieve*. Figure 1 shows the number of papers identified, 
screened, and included.
2.2 | Eligibility criteria
For the purposes of this review, a childhood cancer was de-
fined as a cancer diagnosed in someone up to 18 years of age. 
This allowed us to focus on cancers that occurred at the time 
where most children/adolescents would still be in an educa-
tion setting. Educational attainment was defined as graduat-
ing primary school and/or secondary school, or attending or 
graduating college/university.
To be eligible, papers had to: be full papers; have a quan-
titative design; report primary data; include participants that 
were adults (18 years of age or over) at the time of data col-
lection and who were diagnosed with cancer (or treated with 
a treatment usually used for cancer) when they were younger 
than 18; report educational attainment; include a noncancer 
control group or external comparison population; be pub-
lished in a peer‐review journal, in English; and be conducted 
in a high‐income country.27
2.3 | Data extraction
Titles and abstracts were screened independently by at least 
two reviewers (MM, MDE, AAT, LS). Full text of abstracts 
that were  considered potentially eligible were obtained and 
assessed for eligibilaty by two reviewers; in the event of dis-
agreemnt, the final decision was made by the lead author. 
Reasons for exclusion were recorded and papers could be in-
eligible for multiple reasons.
Data were extracted independently by three reviewers 
(MDE, MM, LS) from each eligible paper on: (a) study lo-
cation; (b) study design; (c) sample size and source of cases 
and controls/comparator group; (d) age at diagnosis and at 
assessment; (e) year of diagnosis; (f) outcomes measured; (g) 
method of data collection from cases and controls/compara-
tor group; and (h) findings.
2.4 | Quality appraisal
Eligible studies were critically appraised independently by 
two reviewers (MM, LS) using a checklist based on the 
Newcastle‐Ottawa Scale (NOS).28 Disagreements were 
carefully discussed and consensus reached. Each paper 
was assessed on eight domains. Each domain was scored 
0 where the domain was missing, 0.5 where the domain 
was partially addressed, and 1 (and for one domain, com-
parability of cases and controls/comparator population, 
2) where the domain was fully addressed in the paper. 
The eight criteria were as follows: (a) Case definition: 1 
if cases were well described; (b) Representativeness: 1 if 
the study was population based; (c) Selection of controls: 
1 if included controls (rather than comparison to national 
statistics); (d) Definition of controls: 1 if clear, detailed 
information was provided; (e) Comparability of controls: 2 
if individually matched; 1 if “selected” from other surveys 
and matched to cases; (f) Assessment of educational attain-
ment: 1 if assessment was based on administrative records 
(rather than self‐report); (g) Ascertainment of educational 
attainment is the same in cases and controls: 1 if yes; (h) 
Nonresponse/loss to follow‐up: 1 if figures reported. We 
considered score of ≥8 as good quality, 5‐7 adequate qual-
ity and ≤4 poor quality.
2.5 | Statistical analysis
The study designs, methods and populations, and the out-
comes assessed were heterogeneous, hence, no formal 
statistical attempt was made to combine the findings in a 
meta‐analysis.
3 |  RESULTS
3.1 | Study selection
Following exclusion of duplicates, the titles and abstracts of 
347 citations were screened. Of these, 148 full‐text papers 
were obtained and read; 14 were eligible for inclusion in the 
review (Figure 1).26 Reasons for exclusion were: educational 
attainment not reported (n = 135), population at diagnosis 
or at assessment was out of the eligible age range (n = 59), 
reviews and commentaries (n = 65); no cancer‐free con-
trols (n = 26); qualitative study design (n = 12); abstracts or 
conference proceedings (n = 8); not reporting primary data 
(n = 6); not peer reviewed (n = 6); data not collected from 
survivors (n = 6); not in English (n = 5); cancers not reported 
separate from other diseases (n = 5).
3.2 | Characteristics of eligible studies
Eleven studies were from Europe, two were from the USA, 
and one from Turkey (Table 1). Two studies had a pro-
spective design and involved linkage of national cancer 
registration, education, and population data29,30; the re-
mainder were retrospective and were based on self‐report 
of educational attainment. The two linkage studies identi-
fied the comparable population without cancer; six stud-
ies compared cancer survivors’ outcomes with data from 
individuals who participated in various surveys31,32; two 
compared results for survivors with national data37,38; and 
five recruited, and collected data from, cancer‐free con-
trol groups (siblings, classmates, or samples of the general 
population).36,39,40 The number of childhood cancer cases 
included in the studies ranged from 51 to 2213. Ten studies 
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included multiple types of cancer; two studies focused only 
on leukemia37,40 and a further two, which included multi-
ple cancer types, reported subgroup analyses for leukemias 
and/or other blood cancers29,32; one study39 included only 
CNS tumors, and a further three reported results for the 
subgroup with these tumors24,27,36; one study included only 
Differentiated Thyroid Carcinoma (DTC).36
Ten studies reported both school‐ and third‐level educa-
tional attainment; usually this represented the highest level of 
education attained although the specific outcomes were differ-
ent across studies. One study only reported school‐level edu-
cation41 and one study only reported postschool education.33 
In one study, the level of education was reported, but it was 
unclear whether these referred to school level alone or both 
school and postschool education.36 Only seven studies used 
the same methods to ascertain educational outcomes from the 
cancer cases and the comparison group.29,30,35,36,40,41 In gen-
eral the studies did not report the age of the survivors (and 
comparators) were when educational attainment was assessed.
3.3 | Quality assessment
Two studies scored 9 out of a possible 9 and were considered 
good quality (Table 2).29,30 Two studies scored 4 or less and 
were considered poor quality.37,38 The remaining 10 studies 
were considered adequate quality. On average, studies scored 
well in terms of selection of controls/comparator population, 
but much more poorly on representativeness of cases, as-
certainment of educational attainment, and comparability of 
ascertained of educational attainment in cases and controls/
comparator population.
3.4 | School‐level educational attainment: 
studies of multiple cancer types
Of the nine studies which included multiple cancer types, 
three reported significantly better school‐level outcomes in 
survivors than controls31,32,38 (Table 3). In contrast, in one 
study, significantly more survivors than controls completed 
only compulsory schooling (9% vs 5%; P < 0.001).34 The re-
maining studies either found modestly, but nonsignificantly, 
poorer educational attainment in survivors (n = 3)30,41,42 or 
no notable difference in educational outcomes between sur-
vivors and controls (n = 2).29,35
3.5 | Postschool educational attainment: 
studies of multiple cancer types
Three of the nine studies which included multiple cancer types 
and reported postschool educational attainment found that sur-
vivors had significantly better postschool outcomes than con-
trols.31,32,38 In contrast, in one study, a significantly smaller 
proportion of survivors than controls obtained a university 
degree (7% vs 11%; P < 0.001), but this was no longer signifi-
cant when the analysis was limited to those aged 27 and older at 
time of assessment of educational attainment.34 The remaining 
five studies found no significant difference in postschool edu-
cational attainment among survivors and controls.29,30,33,35,42
3.6 | Studies reporting individual cancers
All four studies that reported on CNS tumors found evidence 
of poorer educational attainment in survivors than cancer‐free 
controls.29,30,32,39 Findings from the four studies that reported 
on hematological cancers were inconsistent.29,32,37,40 Jacola 
et al40 found lower college graduation rates among ALL 
survivors than controls, and Dumas et al32 reported that sig-
nificantly more leukemia survivors than controls completed 
only middle school or high school and fewer than expected 
were college graduates. In contrast, Zynda et al37 reported 
that more leukemia survivors than controls attained a high 
school diploma while fewer attained only a secondary school 
graduation. Boman et al29 found no difference in completion 
of either only basic education, or third‐level education, in 
leukemia or lymphoma survivors than controls.
In the single study which considered patients with bone tu-
mors,29 there was little difference between than controls in under-
taking postschool education. In the single study which reported 
findings for bone or soft tissue sarcoma survivors,32 significantly 
fewer survivors than controls completed less than middle school 
while significantly more than expected were college graduates. 
In a single study that reported findings for DTC survivors,36 sig-
nificantly fewer survivors obtained high level of education com-
pared to peer controls, however, significantly more survivors 
obtained high‐level education compared to comparators.
3.7 | Treatment
Two studies reported subgroup analyses by treatment re-
ceipt.30,40 Jacola et al40 reported that more survivors who 
received cranial radiotherapy (CRT) completed only grades 
1‐12 of school than survivors who did not receive CRT or 
sibling controls. Similarly, fewer of those who received CRT 
graduated from college. Ghaderi et al30 considered the sub-
group of survivors who received CNS‐directed therapy and 
found that this group—when diagnosed in 1975‐1994, under 
5 years of age, or 10‐14 years—were significantly less likely 
to complete undergraduate education than controls.
4 |  DISCUSSION
This systematic review investigated whether there are differ-
ences in educational attainment between cancer survivors and 
controls, in an attempt to gain a deeper understanding of the 
long‐term effects of childhood cancer, across different cancers 
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and educational systems. Despite the strict criteria that were 
applied for inclusion in the review, the studies still varied in 
design, outcome measures considered, cancers included, and 
the methods of reporting. The variation was exacerbated by 
the fact that they were based in different educational systems. 
Indeed, the extent of heterogeneity precluded any statistical 
combination of the findings. Moreover, only two of the stud-
ies were considered high quality29,30 based on NOS ratings.
Of the 10 papers examining school completion as the 
highest level of education attainment, five reported a higher 
proportion of cancer survivors compared to controls complet-
ing school31,34,37,38 while the other five reported no signifi-
cant differences in school completion between survivors and 
controls.29,30,35,41,42 Of the nine studies that reported post-
school education as the highest educational attainment, two 
reported a higher proportion of controls achieving postschool 
education compared to survivors,30,39 two reported a higher 
proportion of survivors achieving postschool education com-
pared to controls,31,38 and five reported no difference between 
survivors and controls.29,33-35 One paper reported level of ed-
ucation but without indicating what these levels represented, 
with contradictory findings when compared to controls and 
comparators.36 These contradictory findings limit the ability 
to draw clear conclusions on a pattern of educational attain-
ment of childhood cancer survivors overall.
The studies that included only one cancer type or com-
pared findings across cancer types focused mainly on CNS 
tumors and blood cancers. The four studies that reported re-
sults for CNS consistently reported that survivors had poorer 
academic attainment compared to controls,29,30,32,39 which 
could be the result of exposure to cranial radiation,8,15,16 as 
was suggested by Ghaderi et al30 who examined CNS‐directed 
treatment for non‐CNS patients. The two studies that focused 
on leukemia both reported that survivors had favorable edu-
cational attainment compared to controls, although the find-
ings were statistically significant in only one of them.35,37 
Favorable educational attainments for ALL survivors could 
be explained by the higher SES that has been associated with 
ALL in some settings38; SES is also positively associated 
with educational attainments in children43 in general, and in 
cancer survivors in particular.20 However, none of the studies 
adjust for SES in their analysis.
The evidence presented in this review does not point to 
consistently reduced educational attainment among child-
hood cancers in general. This is somewhat surprising given 
the known impact of treatment on cognition.11,12 However, 
not all survivors would have had treatments that could have 
impacted on their cognitive abilities, and the studies reviewed 
generally did not provide detailed information on treatment. 
It is also possible that childhood cancer survivors received 
T A B L E  3  Main findings from the studies in the review, for school‐level and postschool education
 Highest level of education: School Risk estimate
Highest level of 
education: Postschool Risk estimate
Adjustment 
factors
Boman et al 
(2009)39
Did not complete primary school: 
survivors: 8.3%; controls 1.7% 
Completed primary school: 
survivors: 9.6%; controls: 4.4% 
Completed secondary school: 
survivors: 33.7%; controls: 22.4%
Not reported Entered third‐level 
education: 
survivors: 16.9%; 
controls: 17.6% 
Completed third‐level 
education: 
survivors: 31.2%; 
controls: 53.9%
Not reported Highest level of 
educational 
achieved 
(P < 0.001) 
was adjusted 
for sex and age
Boman et al 
(2010)29
Completed basic education only: 
All survivors: 10.8% (leukemia 9.7%; 
lymphoma 7.0%; CNS 15.5%; bone tumors 
3.7%; other cancers 9.4%); controls 8.8% 
Highest attained education—secondary: 
All survivors: 54.6% (leukemia 57.9%; 
lymphoma 53.5%; CNS 55.0%; bone tumors 
57.4%; other cancers 49.2%); controls: 54.4%
Basic education 
only: 
Hematological 
cancers: 
RR = 1.07 
(0.79‐1.45) 
CNS tumors: 
RR = 1.80 
(1.45‐2.23) 
Other cancers: 
RR = 1.05 
(0.82‐1.36)
Post‐secondary 
education: 
All survivors: 34.7% 
(leukemia 32.5%; 
lymphoma 39.5%; CNS 
29.5%; bone tumors 
39.0%; other cancers 
41.4%); controls: 
36.8%.
Post‐secondary: 
Hematological 
cancers: 
RR = 0.92 
(0.79‐1.07) 
CNS tumors: 
RR = 0.69 
(0.58‐0.81) 
Other cancers: 
RR = 1.09 
(0.97‐1.22)
RR controlled 
for sex and 
year of birth, 
residency, 
socioeconomic 
status and 
maternal 
country of 
birth
Dieluweit et 
al (2011)31
Obtained university entrance qualifications 
(high school degree): 
survivors: 52.4%; controls: 38.3%; P < 0.001
Not reported Obtained third‐level 
degree: 
survivors 24.7%; 
controls 17.0%; 
P < 0.001
OR = 0.93 
(0.65‐1.33)
OR controlled 
for school 
education
(Continues)
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 Highest level of education: School Risk estimate
Highest level of 
education: Postschool Risk estimate
Adjustment 
factors
Dumas et al 
(2016)g, 32
Highest attained education 
All diagnoses 
< middle school/no diploma 
Survivors: 11.4%; Expected 16.8% 
Middle school 
Survivors: 6.3%; Expected 6.8% 
Vocational school 
Survivors: 26.0%; Expected: 24.1 
High school 
Survivors: 17.4%; Expected: 18.7% 
Hodgkin's lymphoma 
< middle school/no diploma 
Survivors: 9.1%; Expected 18.7% 
Middle school 
Survivors: 9.1%; Expected 7.4% 
Vocational school 
Survivors: 24.8%; Expected: 25.6% 
High school 
Survivors: 20.7%; Expected: 17.7% 
Bone or soft tissue sarcoma 
< middle school/no diploma 
Survivors: 7.4%; Expected 18.6% 
Middle school 
Survivors: 6.0%; Expected 7.1% 
Vocational school 
Survivors: 25.5%; Expected: 26.0% 
High school 
Survivors: 14.8%; Expected: 17.3% 
CNS tumor 
< middle school/no diploma 
Survivors: 40.6%; Expected 17.5% 
Middle school 
Survivors: 6.7%; Expected 7.0% 
Vocational school 
Survivors: 30.3%; Expected: 24.2% 
High school 
Survivors: 6.9%; Expected: 18.4% 
Leukemia 
< middle school/no diploma 
Survivors: 11.5%; Expected 12.2% 
Middle school 
Survivors: 16.6%; Expected 5.8% 
Vocational school 
Survivors: 13.4%; Expected: 19.4% 
High school 
Survivors: 33.1%; Expected: 22.2% 
Other diagnoses 
< middle school/no diploma 
Survivors: 8.4%; Expected 16.6% 
Middle school 
Survivors: 4.6%; Expected 6.8% 
Vocational school 
Survivors: 27.4%; Expected: 24.0% 
High school 
Survivors: 17.2%; Expected: 18.8%
O/E = 0.7 
(0.6‐0.8) 
O/E = 0.9 
(0.8‐1.1) 
O/E = 1.1 
(1.0‐1.2) 
O/E = 0.9 
(0.8‐1.0) 
O/E = 0.5 
(0.2‐0.9) 
O/E = 1.2 
(0.6‐2.2) 
O/E = 1.0 
(0.7‐1.4) 
O/E = 1.2 
(0.8‐1.8) 
O/E = 0.4 
(0.3‐0.6) 
O/E = 0.8 
(0.5‐1.3) 
O/E = 1.0 
(0.8‐1.2) 
O/E = 0.9 
(0.6‐1.1) 
O/E = 2.3 
(1.8‐2.9) 
O/E = 1.0 
(0.5‐1.8) 
O/E = 1.3 
(1.0‐1.7) 
O/E = 0.4 
(0.2‐0.7) 
O/E = 0.9 
(0.6‐1.5) 
O/E = 2.9 
(1.9‐4.2) 
O/E = 0.7 
(0.4‐1.1) 
O/E = 1.5 
(1.1‐2.0) 
O/E = 0.5 
(0.4‐0.6) 
O/E = 0.7 
(0.5‐0.9) 
O/E = 1.1 
(1.0‐1.3) 
O/E = 1.3 
(1.1‐1.4)
College 
All diagnoses 
Survivors: 38.9%; 
Expected: 33.5% 
Hodgkin's lymphoma 
Survivors: 36.4%; 
Expected: 30.7% 
Bone or soft tissue 
sarcoma 
Survivors: 46.2%; 
Expected: 30.9% 
CNS tumors 
Survivors: 15.4%; 
Expected: 32.8% 
leukemia 
Survivors: 25.5%; 
Expected: 40.3% 
Other diagnoses 
Survivors: 42.4%; 
Expected: 33.8%
O/E = 1.2 (1.1‐1.3) 
O/E = 1.2 
(0.9‐1.6) 
O/E = 1.5 
(1.3‐1.7) 
O/E = 0.5 
(0.3‐0.7) 
O/E = 0.6 
(0.5‐0.9) 
O/E = 1.3 
(1.1‐1.4)
Expected 
numbers take 
account of age 
and sex 
distribution of 
survivors
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 Highest level of education: School Risk estimate
Highest level of 
education: Postschool Risk estimate
Adjustment 
factors
Gerhardt et al 
(2007)41
High school graduates: 
survivors: 39% (22); controls 43% (22); ns
Not reported   None
Ghaderi et al 
(2015)
Highest attained education—intermediatea : 
All survivors 67% (727) (CNS 53% (142); 
CNS‐directed therapy 71% (274); other 
cancers 72% (41)); controls 70% (852 063)
Not reported Completed undergradu-
ate education: 
All survivors 31% 
(418) (CNS 20% (69); 
CNS‐directed therapy 
32% (136); other 
cancers 38% (213)); 
controls 35% (430 018) 
Completed graduate 
education: 
All survivors 7% (135) 
(CNS 4% (18); 
CNS‐directed therapy 
5% (27); other cancers 
10% (90)); controls 9% 
(102 987)
Not reported None
Jacola et al 
(2016)40
Highest attained education: 
Grades 1‐12f 
Survivors treated with CRT: 13%; Survivors 
not treated with CRT 6%: Controls 3% 
Graduated high schoolf 
Survivors treated with CRT: 17%; Survivors 
not treated with CRT 11%: Controls 9% 
Post high school, some collegef 
Survivors treated with CRT: 27%; Survivors 
not treated with CRT 29%: Controls 26%
Not reported Graduated college 
Survivors treated with 
CRT 
Survivors: 43%; 
Controls: 65%; 
P<=0.0001 
Survivors not treated 
with CRT 
Survivors: 53%; 
Controls: 65%; 
P = 0.016
Not reported None
Jóhannsdóttir 
et al 
(2010)33
— — Completed academic 
educationb : 
survivors 32%; controls 
28%
OR = 1.33 
(0.95‐1.88)
OR controlled 
for age and 
gender
Kuehni et al 
(2012)34
Completed only compulsory schooling: 
All ages—survivors 8.7%; controls 5.2%; 
P < 0.001 
Aged 27 and older—survivors 4.6%; controls 
5.9%; P = 0.284
OR = 2.25 
(1.65‐3.07)
Completed compulsory 
educationc : all 
ages—survivors 36.1%; 
controls 24.1%; 
P < 0.001 
Obtained university 
degree: 
all ages—survivors 
7.3%; controls 11.0%; 
P < 0.001; 
aged 27 and older—
survivors 11.3%; 
controls 14.5%; 
P = 0.083 
Vocational training: 
survivors 47.9%; 
controls 59.6%; 
P < 0.001.
Completed upper 
secondary 
education or 
greatera : 
OR = 1.36 
(1.12‐1.74) 
Obtained 
university degreea : 
OR = 0.75 
(0.54‐1.05)
OR controlled 
for age, sex, 
migration 
background, 
place of living, 
and language 
region
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support to overcome the time spent out of school, or that 
they participated in intervention programs to ameliorate the 
adverse cognitive effects of the treatment.44,45 Such inter-
ventions have been found to improve survivors’ educational 
attainment25; however, information on access to, or receipt 
of, such support was not included in the articles included in 
the review.
The observed equivocal picture of educational attain-
ment of childhood cancer survivors could also be partly 
explained by the heterogeneity in the available studies. 
 Highest level of education: School Risk estimate
Highest level of 
education: Postschool Risk estimate
Adjustment 
factors
Löf et al 
(2011)35
Completed compulsory education only: 
aged 19‐24—survivors 12.5% (3); controls 
14.8%; ns; 
aged 25‐42—survivors 3.7% (1); controls 
7.2%; ns 
Upper secondary schooling: 
aged 19‐24—survivors 70.8% (17); controls 
56.9%; n.s; 
aged 25‐42—survivors 44.4% (12); controls 
42.5%; n.s
Not reported Completed tertiary 
education: 
aged 19‐24—survivors 
16.6% (4); controls 
28.4%; ns; 
aged 25‐42—survivors 
51.8% (14); controls 
49.8%; ns
Not reported None
Nies et al 
(2017)36
Low level h 
survivors: 18%; peer controls: 0% 
general population controls: 28% 
Medium level: 
survivors: 39%; peer controls: 40% 
general population controls: 48% 
High Level: 
survivors: 44%; peer controls: 60% 
general population controls: 19% 
Peer controls P < 0.05 
Comparison P < 0.001
Not reported   None
Stam et al 
(2005)42
Completed low level of education onlyd : 
survivors 33.6%; controls 29.4% ns 
Highest attained education—middle leveld : 
survivors 50.3%; controls 50.6% ns
Not reported Attained high level of 
education: 
survivors 16.1%; 
controls 20.0%; ns
Not reported None
Yagci‐Kupeli 
et al 
(2013)38
Primary school only: 
survivors 21.5% (43); controls 45.0%; 
P < 0.001 
Highest attained—high school: 
survivors 55.5% (111); controls 29.9%; 
P < 0.001
Not reported Attended university: 
survivors 23.0% (47); 
controls 11.1%; 
P < 0.001
Not reported None
Zynda et al 
(2012)37
Highest level of education‐ school‐leaving 
certificatee : 
Survivorsh : 15.4%; controls: 27.7% 
Highest level of education—intermediate 
school‐leaving certificatee : 
Survivorsh : 33.4%; controls: 33.5% 
Highest level of education—high school 
diplomae : 
Survivorsh : 51.2%; controls: 38.8%
Not reported   None
ns, not significant.
aIncludes basic upper secondary education, final year upper secondary education, and postschool nontertiary education. 
bDefined as 4 y or more at a university of similar educational institution. 
cAdditional schooling, usually during ages 19‐27, leading to higher degrees/managerial jobs in specific professions. 
dLow: primary education, technical, and vocational training, lower and middle general secondary education; middle: middle vocational education, higher general 
secondary education, preuniversity education. 
eLevel attained or currently strived for. 
fPercentages estimated by review authors from chart in appendix of Jacola et al; results for all survivors combined not reported in paper. 
gPercentages calculated by review authors from figures given in paper. 
hLevel of education completed (ie, whether school or postschool) is not specified in the paper. 
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Most studies scored poorly on how educational attainment 
was ascertained and comparability of this between cases 
and controls. These weaknesses were exacerbated by the 
fact that studies defined/categorized attainment in different 
ways, probably reflecting (at least in part) the differences 
in education systems, and the complexity of measuring ed-
ucational attainment cross‐nationally. This highlights the 
need to develop standardized measures for assessing edu-
cational attainment, that is, measures that would allow for 
pooled analysis cross country for individual cancer types. 
However, given the differences in educational systems, 
reaching a consensus on how and when to assess survivors’ 
attainment may be challenging. In the meantime, improved 
reporting of individual studies would be helpful. For exam-
ple, Koch et al,20 provided a clear description of the Danish 
education system—including such information could, in 
itself, improve ability to compare findings across different 
education systems.
Few studies were clearly population based, indicating the 
need for larger, population based, longitudinal studies that 
will track cancer types and treatment, as well as attainment 
over time from primary, through secondary and third‐level 
education. Such information would allow researchers to bet-
ter understand the differences in educational attainment of 
different groups of childhood cancer survivors and be better 
able to collect data on the use of interventions or supports 
related to education among survivors and assess their “real‐
world” effectiveness.
5 |  LIMITATIONS
The limitations of this review can be divided into limitations 
related to the review process and limitations related to the 
evidence. While we have attempted to achieve a complete 
literature search, it is possible that we failed to identify some 
relevant papers. Our search was predominantly electronic, 
which may result in the exclusion of papers that could only 
be found in manual searches. Additionally, limiting the re-
view to papers written in English will have excluded any oth-
erwise eligible papers in other languages.
In terms of the evidence itself, the most substantial lim-
itation is the heterogeneity of the studies; this limited our 
ability to compare and contrast the findings and to conduct 
a formal statistical combination of the results. The studies 
varied in the method of recruitment of cases and controls, 
most were retrospective and they differed in types of can-
cers and reporting on different cancers separately, and in 
the statistical analysis that was carried out. Additionally, 
of the 14 papers that were reviewed, only two were catego-
rized as good quality on the NOS. While we were still able 
to draw some conclusions, the lack of high‐quality research 
in this area is a substantial limitation.
6 |  CONCLUSIONS
The evidence reviewed here paints a mixed and inconsistent 
picture of educational attainment among childhood cancer 
survivors. The evidence tentatively suggests that, in some 
cancers, mainly CNS, educational attainment of survivors 
is poorer than that for children without cancer; for other 
cancers, the evidence is less strong or inconsistent. These 
findings strongly demonstrate the need for high‐quality, pop-
ulation‐based studies, underpinned by a more coordinated 
and standardized data collection.
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